Skip to main content
Trials logoLink to Trials
. 2024 May 30;25:350. doi: 10.1186/s13063-024-08195-6

Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

Taylan Gurgenci 1,8,, Janet Hardy 1, Georgie Huggett 1, Karyn Foster 1, Anita Pelecanos 2, Ristan Greer 3, Jennifer Philip 4, Alison Haywood 5, Ruwani Mendis 4, Patsy Yates 6, Phillip Good 1,7,8
PMCID: PMC11140951  PMID: 38816764

Correction : Trials 25, 293 (2024)

https://doi.org/10.1186/s13063-024-08091-z

Following the publication of the original article [1], we have been notified that Jennifer Phillip’s affiliation should read as 'University of Melbourne' instead of 'Western Health'.

The original article has been corrected.

Reference

  • 1.Gurgenci, et al. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial. Trials. 2024;25:293. doi: 10.1186/s13063-024-08091-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES